| Indicators | Browse All

Envista Holdings Corporation (NVST)

Healthcare | Medical Instruments & Supplies | Brea, United States | NYSE
26.22 USD +0.31 (1.196%) ⇧ (July 13, 2026, 4 p.m. EDT)
After hours: 26.37 +0.15 (0.572%) ⇧ (July 13, 2026, 6:22 p.m. EDT)

Short-term:★★★⯪☆Long-term:★★★⯪☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:29 a.m. EDT

The immediate setup looks like a classic 'value trap' waiting for a catalyst. Fundamentally, the company is showing signs of life with a 14% revenue growth rate and a massive earnings revision upward (EPS jumping from $0.41 to $1.57 forward), which explains why the forward P/E has compressed so sharply relative to the trailing multiple. However, the stock is still technically trapped below its 50-day average, and the statistical forecast model leans slightly negative for the next month, creating a tension between the improving business metrics and the lagging price action. The short-term rating sits at 3.5 because the momentum is building but not yet explosive; the recent price action shows volatility rather than a clean trend, and the statistical model warns of a potential dip. The options market tells a different story, screaming 'bullish' with heavy call buying at the $30 level, which suggests smart money sees the current price as a floor. This divergence creates a high-risk, high-reward scenario: if the earnings beat translates into a sustained price discovery process, the gap between the low forward P/E and the high analyst targets offers significant room to run. However, without a confirmed break above the 50-day moving average, the path of least resistance remains slightly downward in the very short term. Long-term, the picture is much brighter. The multi-year trajectory is no longer a structural decline; the asset has recovered significantly from its lows, and the latest year-on-year performance is positive. The combination of strong revenue growth, expanding margins, and a fortress-like balance sheet (low debt-to-equity) supports a solid buy rating. It is no longer a distressed asset but a turnaround story that has stabilized. The lack of a dividend is irrelevant here; the equity is being reinvested into growth, which is the correct strategy for a company in this phase. Investors should view the current price as a discount to the intrinsic value implied by the forward earnings and the analyst consensus, making it a compelling hold for the medium-to-long term despite the short-term noise.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.075196
AutoETS0.084821
AutoARIMA0.084943
MSTL0.093981
MSTL_1260.097571
MSTL_90_1260.103770
MSTL_900.107117

Forecast horizon: 60 days | Selected: AutoTheta

Forecast Reliability
Score 47%
H-stat 0.79
Ljung-Box p 0.000
Jarque-Bera p 0.090
Excess Kurtosis -1.38
Attribute Value
Sector Healthcare
Debt to Equity Ratio 51.606
Revenue per Share 16.929
Market Cap 4,266,725,888
Trailing P/E 63.95
Forward P/E 16.67
Beta 0.86
Profit Margins 2.41%
Website https://envistaco.com

As of July 11, 2026, 6:29 a.m. EDT: Speculators are heavily positioning for upside, evidenced by massive open interest in $30 and $35 calls compared to negligible put volume. The $30 strike acts as a significant barrier where traders are betting on a breakout, while ATM calls show new inflow. Conversely, put activity is sparse and concentrated at lower strikes ($17.50-$20.00), suggesting limited hedging demand and a bullish bias among retail and speculative capital.


Info Dump

Attribute Value
52 Week Change 0.29355967
Address1 Building E
Address2 200 South Kraemer Boulevard
All Time High 52.03
All Time Low 10.08
Ask 26.32
Ask Size 400
Audit Risk 2
Average Analyst Rating 2.2 - Buy
Average Daily Volume10 Day 2,989,340
Average Daily Volume3 Month 3,134,913
Average Volume 3,134,913
Average Volume10Days 2,989,340
Beta 0.861
Bid 26.31
Bid Size 700
Board Risk 2
Book Value 18.904
City Brea
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 4
Country United States
Crypto Tradeable 0
Currency USD
Current Price 26.22
Current Ratio 2.44
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 26.45
Day Low 25.78
Debt To Equity 51.606
Display Name Envista
Earnings Call Timestamp End 1,785,960,000
Earnings Call Timestamp Start 1,785,960,000
Earnings Growth 1.3
Earnings Quarterly Growth 1.15
Earnings Timestamp 1,785,960,000
Earnings Timestamp End 1,785,960,000
Earnings Timestamp Start 1,785,960,000
Ebitda 383,100,000
Ebitda Margins 0.13643
Enterprise To Ebitda 12.459
Enterprise To Revenue 1.7
Enterprise Value 4,773,126,144
Eps Current Year 1.43213
Eps Forward 1.57319
Eps Trailing Twelve Months 0.41
Esg Populated 0
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 714 817 5450
Fifty Day Average 24.8602
Fifty Day Average Change 1.3597984
Fifty Day Average Change Percent 0.054697804
Fifty Two Week Change Percent 29.355967
Fifty Two Week High 30.42
Fifty Two Week High Change -4.200001
Fifty Two Week High Change Percent -0.13806708
Fifty Two Week Low 18.77
Fifty Two Week Low Change 7.449999
Fifty Two Week Low Change Percent 0.3969099
Fifty Two Week Range 18.77 - 30.42
Financial Currency USD
First Trade Date Milliseconds 1,568,813,400,000
Float Shares 162,031,447
Forward Eps 1.57319
Forward P E 16.666773
Free Cashflow 216,337,504
Full Exchange Name NYSE
Full Time Employees 12,000
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.55254
Gross Profits 1,551,600,000
Has Pre Post Market Data 1
Held Percent Insiders 0.0047999998
Held Percent Institutions 1.1340001
Implied Shares Outstanding 162,727,923
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Long Name Envista Holdings Corporation
Market us_market
Market Cap 4,266,725,888
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_629627778
Most Recent Quarter 1,775,174,400
Net Income To Common 67,700,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 4,216,280,484
Number Of Analyst Opinions 14
Open 25.92
Operating Cashflow 272,100,000
Operating Margins 0.09865
Overall Risk 3
Payout Ratio 0.0
Phone 714 817 7000
Post Market Change 0.15000153
Post Market Change Percent 0.57208824
Post Market Price 26.37
Post Market Time 1,783,981,374
Previous Close 25.91
Price Eps Current Year 18.308393
Price Hint 2
Price To Book 1.3870081
Price To Sales Trailing12 Months 1.5194352
Profit Margins 0.02411
Quick Ratio 1.932
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.1875
Region US
Regular Market Change 0.309999
Regular Market Change Percent 1.19645
Regular Market Day High 26.45
Regular Market Day Low 25.78
Regular Market Day Range 25.78 - 26.45
Regular Market Open 25.92
Regular Market Previous Close 25.91
Regular Market Price 26.22
Regular Market Time 1,783,972,803
Regular Market Volume 1,703,456
Return On Assets 0.030079998
Return On Equity 0.02214
Revenue Growth 0.144
Revenue Per Share 16.929
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 5
Shares Outstanding 162,727,923
Shares Percent Shares Out 0.060500003
Shares Short 9,836,917
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 11,848,235
Short Name Envista Holdings Corporation
Short Percent Of Float 0.0677
Short Ratio 3.69
Source Interval 15
State CA
Symbol NVST
Target High Price 35.0
Target Low Price 21.0
Target Mean Price 29.42857
Target Median Price 30.0
Total Cash 1,082,800,000
Total Cash Per Share 6.654
Total Debt 1,589,200,000
Total Revenue 2,808,100,096
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.41
Trailing P E 63.951218
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 23.84205
Two Hundred Day Average Change 2.3779488
Two Hundred Day Average Change Percent 0.09973759
Type Disp Equity
Volume 1,703,456
Website https://envistaco.com
Zip 92,821-6208